Open access peer-reviewed chapter

Cyclodextrin Nanosponges: A Promising Approach for Modulating Drug Delivery

By Sunil Kumar, Pooja Dalal and Rekha Rao

Submitted: March 15th 2019Reviewed: November 4th 2019Published: December 24th 2019

DOI: 10.5772/intechopen.90365

Downloaded: 374


Nanotechnology showed great promise and impact on administration of therapeutic agents owing to its advantages over contemporary delivery systems. Nanoscale carriers like nanosponges represent a novel category of hyper cross-linked polymer structures with nanosized cavities which can be filled with variety of active moieties (hydrophilic as well as hydrophobic). These nanocarriers can circulate around the body until they found the specific target site and adhere on the surface and release the active moiety in a predictable and controlled manner, resulting in more effective delivery of a given dosage. Nanosponge technology helps to reduce drug associated side effects, improve stability, increase elegance and improve the flexibility of formulations, administered orally, parenterally and topically. Among nanosponges, cyclodextrin-based nanosponges (CDNS) are smart versatile carriers studied widely for drug delivery applications. Statistically, it have presented that approximately 40% of active moieties marketed currently and about 90% of active moieties in their preliminary phase confront problems regarding to solubility. In the past decade, the number of studies describing CDNS has dramatically increased. In the present chapter, scientists working in arena of nanotechnology can get an idea of fabrication, characterization and therapeutic utilities of nanosponges.


  • drug targeting
  • solubility enhancement
  • porosity
  • nanocarrier
  • controlled release

1. Introduction

The development of new active moiety is very expensive and time consuming. Currently, it is estimated the bringing a new portion of active moiety through discovery, development, clinical trials and regulatory approval will take a decade and cost approximately $120 million. Therefore, an attempt has been made to improve the safety efficacy relationship of established drugs using a variety of methods, such as individualized drug therapy, therapeutic drug monitoring and dose titration. The delivery of active moieties at controlled rate and targeted delivery have attracted the attention of research community and hence, pursued vigorously [1, 2, 3, 4]. Further, effective and safe delivery of therapeutic drug molecules has always posed challenge for formulation scientists. For this purpose, numerous nanocarriers have been fabricated and explored. Nanoformulations are highly multifunctional delivery systems possessing a range of applications such as enhanced solubility, stability, specific targeting, on-demand release and degradation within suitable period of time [5]. Nanoformulations and nanoparticles have already been applied as carriers of active moieties with great success; and they have an even greater potential for many applications, like gene therapy, anti-tumor therapy, radiotherapy and AIDS therapy, in the delivery of virostatics, antibiotics, proteins and vaccines [6]. Among the various novel forms of drug delivery nanovehicle, colloidal systems like nanosponges have emerged as promising and potential carrier for promising drug delivery of tough molecules in the past few decades [5] because other novel carrier systems have their own drawbacks enlisted in Table 1.

S. No.Novel drug carrier systemsLimitationsReferences
1MicrospheresPremature release of active molecules, deficient entrapment of active molecules, Expeditiously taken up by reticular endothelial system (RES)[19]
2LiposphereWeak loading capacity, limited chemical and physical stability during storage, rapid drug leakage,[20]
3Polymeric NanoparticleChallenging large-scale up, polymer toxicity,[21, 22]
4Solid lipid NanoparticleInsufficient stability and reproducibility, problematic sterilization, low payload[23]
5Nanolipid CarriersSterilization difficulties[23, 24]
6MicelleNot good for hydrophilic drugs[25]
7DendrimersPolymer dependent biocompatibility[26]
8LiposomeWeak load capacity, poor chemical and physical stability on storage, rapid drug leakage,[20, 27]
9NiosomeLess skin penetration[28]
10TransferosomeChemically unstable, very expensive[29]
11SphingosomeLow entrapment efficacy, high cost of sphingolipids[30]
12EthosomePoor yield[31]
13PhytosomesLow stability[32]

Table 1.

Novel drug carrier systems with their limitations.

Nanosponges are a new class of structures based on hyper reticulated polymers that have cavities in the nanorange [7, 8]. Nanosponge technology offers pay load of active moieties and thought to help in reducing side effects, increase elegance, improve formulation flexibility and stability. These are non-mutagenic, non-irritating, non-toxic and non-allergenic. In comparison with other nanostructres, NS are insoluble in organic solvents and water. NS are non-toxic, porous, biodegradable and highly stable (up to 300°C) [9]. These nanostructures are able to transport both hydrophilic and lipophilic moieties and improve the solubilization efficacy of drugs. Nanosponge based drug delivery system is used to improve the performance of drugs administered orally, parenterally, pulmonary and topically [10]. Many active moieties with different pharmacological activities, structures and solubility have been encapsulated in NSs, including camptothecin, paclitaxel, doxorubicin, dexamethasone, 5-fluorouracil, itraconazole, nelfinavir mesylate, progesterone, tamoxifen and resveratrol [11]. Further, we acknowledge some excellent reviews that have been published earlier on nanosponges [8, 12, 13, 14, 15]. Some of the well-known nanosponges are titanium based NS, silicon NS and cyclodextrin NS [16]. Nanosponges possess various attractive features [17] like

  • Can be employed to mask unpleasant flavors and to turn liquid substances to solids

  • Targeted site specific drug delivery.

  • Being suitable aqueous solubility, the hydrophobic drugs can be encapsulated in these, after mixing with cross-linker.

  • Less harmful side effects (since small amount of the active moiety is in contact with healthy tissue).

  • Particle size can be varied by using different proportion of cross-linker to polymer.

  • Easy to scale-up.

  • Simple method production

  • The drug profile can be tailored from fast, medium to slow release as per need.

  • Gives predictable release.

Despite of these advantages, nanosponges have some limitations also. Only small molecules can be entrapped which depend on loading capacities [18]. Cyclodextrin nanosponges can be categorized into four successive generations, on the basis their chemical configuration and features (Table 2).

GenerationCategorySub categoryReferences
FirstPlain nanospongesCyclodextrin-based urethane nanosponges ether nanosponges, cyclodextrin-based carbonate nanosponges, ester nanosponges[33, 34, 35, 36]
SecondModified nanospongesFluorescent carbonate nanosponges, fluorescent carboxylated nanosponges, electrically charged CD-NSs, hydrophobic NSs[37, 38]
ThirrdStimuli nanospongespH responsive cross-linked CD based hydrogels, glutathione-responsive NSs, aminocyclodextrin nanosponges[39, 40, 41]
FourthMolecularly imprinted nanospongesMolecularly imprinted polymers based CD nanosponges[42, 43]

Table 2.

Evolution of cyclodextrin based nanosponges.


2. Architecture of nanosponges

Typically, nanosponges have been constructed from cyclodextrin cross-linked with organic carbonates. Nanosponges mainly comprise of three components- polymer cross linking agent and drug moiety [44].

Nature and type of polymer used can impact the formulation and the performance of NS. The selection of polymer relies on the nature of drug and purpose for which drug is encapsulated. For drug targeting the polymer should possess the capacity to bind with specific ligands. The capacity of the polymer to be cross-linked depends on its active and functional groups to be substituted [44]. Polymers used for architecting the NS are include polyvinyl alcohol (PVA), ethyl cellulose, polymethylmethacrylate, hyper connected polystyrenes, cyclodextrins and their derivatives like methyl beta cyclodextrins, alkyloxycarbonylcyclodextrins [45]. Among these, cyclodextrins (CDs) have been the most popularly employed for fabrication of nanosponges. These cone-shaped truncated cyclic oligosaccharides are comprised of glucopyranose units aligned around the hydrophobic cavity that may lodge guest moieties owing to inclusion complexes formation [46]. The basic physicochemical features of CD have been discovered in the early 1950s and since then they have been applied to improve the pharmaceutical and physicochemical properties, like stability, solubility and bioavailability of active moieties [47]. Conventionally, these nanosponges have been applied for decontamination of water [48]. However, nowadays they have been investigated and employed as nanocarriers for drug delivery in the field of pharmaceuticals.

Cyclodextrin complexes prepared with biocompatible hydrophilic polymers have been reported to enhance the solubility of encapsulated categories in aqueous media. Recently, it has been described that, by reacting cyclodextrins with cross-linkers, a new hyper-crosslinked nanostructured material can be obtained; these are termed as nanosponges [49].

Selection of crosslinker depends on the structure of polymer employed and active moiety to be incorporated [44]. Efficient crosslinkers help to transform molecular nanocavities into three-dimensional nanoporous products. By varying the degree of crosslinking, either hydrophobic or hydrophilic matrix can be formulated and possesses ability to entrap targeted moieties. By taking epichlorohydrin as a crosslinker, hydrophilic nanosponges can be developed, which can modify the amount of active moiety release, increase the absorption of active moiety through biological barriers and act as a potential system for immediate release formulations. Other cross-linking agents, like pyromellitic anhydride, diphenyl carbonate, diisocyanates, diarylcarbonates, glutarldehyde, carbonyldiimidazoles, 2,2- bis(acrylamido) acetic acid and carboxylic acid dianhydrides result in hydrophobic nanosponges [16, 50].

3. Engineering of cyclodextrin based nanosponges

Nanosponges are synthesized depending on type of delivery system, polymer and nature of drug and solvents [14]. Various approaches used for formation of nanosponges are (Table 3).

Types of nanospongeCrosslinkersExample of crosslinkersMethodEncapsulated drugsReferences
Cyclodextrin carbonate nanospongesCarbonyl cross-linkersDiphenyl carbonate, Carbonyl diimidazole, Dimethyl carbonateSolvent extraction, Thermal desorptionL-DOPA, erlotinib, quercetin, telmisartan, curcumin, reservertol, tamoxifen, paclitaxel, Itraconazole, Camptothecin,[43, 51, 52, 53, 54, 55, 56, 57, 58, 59]
Cyclodextrin carbomate nanospongesDiisocyanate cross-linkersHexamethylene diisocyanate and Toluene diisocyanateSolvent methodDextromethorphan, Steroids, Dyes and Naringin[60, 61, 62, 63]
Cyclodextrin anhydride nanospongesAnhydride cross-linkersPyromellitic dianhydride, Ethylenediaminetetraacetic acid dianhydrideSolvent methodIbuprofen, doxorubicin, meloxicam, acetylsalicylic acid and strigolactones[36, 39, 64, 65, 66]
Epichlorohydrin cyclodextrin nanospongesEpichlorohydrin cross linkersEpichlorohydrinSolvent methodCreatinine, cilazapril captopril and enalapril[67, 68]

Table 3.

Engineering of cyclodextrin based nanosponges.

3.1 Techniques for synthesis of cyclodextrin based nanosponges

Several techniques have been reported for synthesis of nanosponges, however melt method and solvent evaporation techniques have been widely reported in literature for preparation of these porous colloidal nanostructures (Figure 1).

Figure 1.

Various techniques for fabrication of nanosponges.

An account of various methods that have been proposed is presented below:

3.1.1 Melt method

In brief way, the cross-linking agent is melted with CD and all components are homogenized and heated at 100°C with stirring magnetically for 5 hrs. Then, above matrix is allowed to cool. Frequent bathing is done to eliminate by-products and unreacted components [47].

3.1.2 Solvent evaporation technique

In solvent evaporation method, the fusion step is avoided and solvents like dimethylsulfoxide (DMSO) or dimethylformamide (DMF) are employed to solubilize the cross-linking agent. Polymer is mixed with solvent (polar aprotic) and the mixture obtained is put in solution of cross-linker and refluxed for 1–48 hrs. By adding cold solution to a large surplus of distilled water, the product is achieved. Finally, filtration is done to recover of the final product and is purified using Soxhlet extraction for prolonged periods. The product achieved is spherical and solid nanostructures with high water solubility either by non-inclusion or inclusion mechanism. The size of NS can be reduced by high pressure homogenization where water suspension of prepared nanosponges is homogenized at constant speed for 10 min [48, 49, 69].

3.1.3 Ultrasound-assisted synthesis

In ultrasound-assisted fabrication, in first, cyclodextrins are reacted with cross-linking agents under ultrasound without solvents. Anhydrous β-CD and DPC are taken in a vial and put in an ultrasound bath, pre-filled with water (at 90°C) and sonicated for 5 hrs. Furthermore, crystallization and purification steps are same as in solvent evaporation and melt technique [70].

3.1.4 Microwave assisted synthesis

It is the simplest method for synthesizing of CDNS using microwave irradiation, remarkably retards the reaction time. The resultant NS possess higher degree of crystallization. In comparison to common melt method, microwave assisted fabrication had exhibited four time reduction in reaction time. The process led to production of particle homogeneous distribution and crystallinity [52].

3.2 Drug loading into blank NS

Crystal structure of the active moiety acts as one of the important criteria that determine its complex efficiency with CD and nanosponges. Paracrystalline and crystalline NS vary in the drug loading capacities. When compared, crystalline NS result in higher drug pay load the paracrystalline NS [47, 58, 71]. The porous cross-linked blank NS have numerous interactive sites for inclusion of drug moieties than parent CD. Further, these possess numerous mesh polarities owing to hydrophobic channels of CD which are enclosed by hydrophilic nanocavities of the polymeric matrix, allowing for large interactions with guests of variable lipophilicities and structures [72]. The resultant polymeric network of NS may be responsible for NS protection and solubilization compared to original CD as shown in Figure 2 [58, 71]. The active moieties are entrapped into nanopores of blank nanosponges by dispersing them within drug dispersion and consequently freeze drying. The solvent evaporation is one another method reported for loading active moieties into NS using organic solvents suitable for dissolving the active moiety. Finally, NS are added to the prepared active moiety dispersion and triturated until the solvent evaporates [47, 73, 74].

Figure 2.

Schematic representation of engineering of cyclodextrin based nanosponges.

4. Analytical techniques to characterize nanosponges

4.1 Spectroscopic techniques

Spectroscopic analytical tools represent a complementary tool to evaluate nanosponges. The variation in properties such as fluorescence intensity, wave number, absorbance and NMR shift of NS can be investigated by different spectroscopic analytical tools.

4.1.1 Ultraviolet: Visible spectrophotometry

To analyze NS in solution (liquid medium), UV–Visible spectrophotometry is a fast, simple, valuable and economic tool. The solubilization efficacy of various molecules such as telmisartan (296 nm) [53], acetyl salicyclic acid (234 nm) [65], resveratrol (303 nm) [55], repaglinide (283 nm) [75], quercetin (372 nm) [76] and efavirenz (286 nm) [73] entrapped in NS have been analyzed using this tool.

Anandam and Selvamuthukumar checked payload, stability assay in simulated intestinal fluid, in vitrorelease, metal chelating and photostability investigation for quercetin NS via this spectrophotometeric tool (λmax 372 nm) [76].

4.1.2 Fourier-transform infrared spectroscopy

It is major employed technique for characterization of nanosponges. In general, measurements of FTIR absorption are carried out on dry samples, in the range 400–4000 cm−1 [77]. In case of nanosponges, during the reticulation (cross linking), the vibrational modes of cross-linkers, polymers and moieties are displayed from parent positions, broadening or disappearance of the prominent peaks of the molecule, polymer and cross-linkers [78, 79].

In FTIR spectra of the placebo NS, bands that varies from 1700 to 1750 cm−1 evidences the carbonate bond. Although, the parent polymer for NS fabrication, β-CD does not show peak at 1750 cm−1 in FTIR spectrum [76]. Cavalli and his colleagues explored the occurrence of carbonate bond (1700 cm−1) in NS [80].

4.1.3 Raman spectroscopy (RS)

Nowadays, it is suggested as a useful analytical tool to study drug entrapment in NS [81]. Not only this, it can be employed together with FTIR to provide a better image to investigate interactions of active moiety and NS. Swaminathan and his colleagues performed RS to investigate dexamethasone and nanosponge interaction. On complexation with nanosponges, the prominent bands of the dexamethasone at 1620, 1480, 1440, 950 and 680 cm−1 in Raman spectra of the active moiety were substantially masked or displaced, advocating the inclusion phenomenon [82].

4.1.4 Nuclear magnetic resonance

It is based on the principle of radiofrequency radiation absorption by atomic nuclei having non zero spins in a high magnetic field [83]. Olteanu and co-workers performed the physicochemical characterization of NS using 1H-NMR. High alteration in the chemical shift (0.47–0.24 ppm) of repaglinide A ring protons was observed. It was envisioned that inclusion in hydrophobic pores of CD and steric hinderance owing to CD substitution, have been considered responsible for interaction phenomenon [75].

4.2 Differential scanning calorimetry

It is a thermoanalytical technique to measure the change in physical or chemical properties of nanostructures and their fabricating materials owing to alteration in temperature. In general, thermal processes (both exothermic and endothermic) are evidenced by the peak direction [84]. This tool explored the exothermic and endothermic processes at the temperature range from −120 to 600°C [85, 86, 87, 88]. The thermal behavior of the various drugs (dexamethasone, furbiprofen, doxorubicin [80], Itraconazole [59], camptothecin [58], resverarol [55], amino salicylic acid [65], gamma-oryzanol [89], telmisartan [53], curcumin [54], acyclovir [37], quercetin [76] and meloxicam [64]) entrapped in the NS was examined by DSC.

The complete disappearance of the therapeutic molecule fusion peak in graph of the NS complex is commonly considered as a confirmatory evidence of the encapsulation of therapeutic molecule within the NS cavity [90]. This may be due to conversion of the crystalline nature to amorphous ones [91]. Other evidence for confirming NS fabrication reported by research scientists include alterations in temperature peak and shape of cyclodextrins, alongwith disappearance of active moiety fusion peak and appearance of new peaks [92].

4.3 Thermogravimetric analysis

Thermogravimetric analysis (TGA) is crucial for supply of fundamental data for NS characterization. Due to its very simplicity, relative reliability and rapidity, TGA is widespread approach to solid-state characterization of nanosponges.

TGA chart of dexamethasone, quercetin, silibinin, apple polyphenols NS have been explored. In drug loaded NS thermograms, endotherms of the pure drug disappeared fully, evidencing the potential encapsulation of these molecules in nanostructures [82, 93, 94].

4.4 X-ray diffraction techniques

It gives detailed information on phases, texture, structures and other structural parameters (crystallinity, crystal defects and deformation) [95]. Unlikely thermal techniques, sample does not suffer any physical or chemical changes during analysis. Furthermore, XRPD studies can support the results of thermal methods. The complete amorphization of the sample in DSC analysis, can be validated by this technique.

Crystalline and paracrystalline nature of NS and porosity can be revealed using this technique. A number of molecules (acetyl salicylic acid [65], camptothecin [58], telmisartan [53], resveratrol [55], acyclovir [37], quercetin [76], meloxicam [64], curcumin [54], and dexamethasone [82]) encapsulated in nanosponges have been evaluated using this technique.

4.5 Microscopic techniques

Microscopy can be used as an imaging analytical technique for qualitative analysis of NS with respect to their aggregation, size and shape. This section provides information on the microscopic methods like AFM, SEM, TEM, and CLSM that are properly used for NS characterization [96].

Scanning electron microscopy is used for observation of surface processes and is capable of obtaining images of bulky samples with a greater depth. It is also employed in solid state evaluation of nanosponges [97]. The topographic changes (related to the interactions of the polymer, active moiety and cross-linking agent) are provided [98]. Various pharmacological active molecules like resveratrol [55], telmisartan [53], dexamethasone [82], and meloxicam [64] have been explored microscopically using SEM.

A nanoscale imaging tool, TEM is used to visualize and characterize various types of nanoparticles [99, 100]. It is relatively expensive and slow technique. Surface morphology via TEM has also been performed for several NS such as ibuprofen [36], quercetin [76], acyclovir [37], paclitaxel [57], dexamethasone [82], camptothecin [58], resveratrol [55], acetyl salicylic acid [65].

Recently developed microscopic technique with high resolution, atomic force microscopy (AFM) is used for viewing atoms and molecules [101]. AFM has been applied to image the molecular nature of β-CDNS in the distilled water and to investigate their mechanical properties. The paracrystalline NS presented spherical colloidal structures (nearly 600 nm), whereas the crystalline NS presented the spectacular crystal planes (nearby 500 nm) [82].

Confocal laser scanning microscopy (CLSM) is recently emerging tool to improve the optical contrast and resolution of sample graph [102]. Lembo and his co-workers examined carboxylated NS loaded with acyclovir for cellular uptake of nanopreparation through CLSM. For this, fluorescent carboxylated NS were prepared [37].

4.6 Measurement of zeta potential

The zeta potential (ZP) is employed to measure the electrokinetic potential of nanomedicines. Simply, it is used for quantifying the charge [103]. To investigate the charge on the nanostructures, ZP must be carried out by suspending them in distilled water or suspension medium [104]. CDNS have been evaluated via the electrophoretic light scattering technique [53, 80, 105]. In practice, ZP predicts surface charge and colloidal stability of nanomaterials.

5. Nanosponges in drug delivery

Owing to their versatile, biocompatible and nanoporous nature, nanosponges have variety of applications in pharmaceuticals, cosmetics, agriculture, environment, food and polymer industry [55, 80, 106, 107, 108]. Among these, they have been predominantly studied for drug delivery. Numerous active molecules including lipophilic and hydrophilic actives and volatile oils can be conventionally entrapped in these multifaceted nanostructures for solubility and stability enhancement and for controlled delivery [7]. Hence, these novel carriers have attracted much interest of formulation scientists as they hold promise in addressing other challenges like poor bioavailability, permeation and therapeutic activity [69]. Cyclodextrin nanosponges have also been explored for drug delivery and drug targeting for cancer management [40, 109, 110]. In the following sections, information regarding their applications in pharmaceutical field has been summarized (Table 4).

Drug candidateCategoryRoute of administrationRemarksReferences
DexamethasoneAnti-inflammatoryOral, ParenteralImproved aqueous solubility[80, 82]
FlurbiprofenAnti-inflammatoryOralImproved aqueous solubility[80]
DoxorubicinAntineoplasticParenteralEnhanced aqueous solubility[80]
ItraconazoleAntifungalOral, TopicalImproved solubilization efficiency[59]
TamoxifenAntiestrogenOralEnhanced pharmacokinetic activity of drug[56]
ResveratrolAntioxidantOral, TopicalEnhanced permeation, stability and cytotoxicity against HCPC-1 cells[55]
PaclitaxelAntineoplasticParenteralIn vitroenhancement of anticancer activity[57, 111]
CamptothecinAntineoplasticParenteralInhibits the adhesion and migration of tumor cells[58]
CurcuminAnti-cancerOralHigher solubilization potential[54, 112]
Acetylsalicylic acidAnalgesicOralControlled release[65]
AcyclovirAntiviralOral, topical, parenteralEnhanced antiviral activity against HSV-1 (clinical isolates)[37]
Gamma-oryzanolAntioxidantTopicalImproved antioxidant potential and photostability[89]
RepaglinideHypoglycemic agentOralSolubility enhancement[75]
Apple polyphenols (Rutin, phloridzin and chlorogenic acid)Antioxidant antiaging and anti-inflammatroyTopicalHigh degree of retention and protection[93]
TelmisartanAntihypertensiveOralImproved intrinsic solubility and bioavailability[53]
EfavirenzAnti HIVOralBioavailability enhancement[73]
LansoprazoleAntiulcerOralProlonged drug release[113]
Tamoxifen and quercetinAnti-cancerDual drug delivery[114]
LysozymeAntihypcaalcemicOralInhibit depletion of calcium in antibiotic associated hypocalcemic condition[105]
MeloxicamAnti-inflammatory and analgesicOralControlled release[64]
QuercetinAntioxidantEnhanced photostability and anti-oxidant activity; Improved dissolution profile[76]
TazaroteneAnti acnetopicalImproved bioavailability and skin retention of drug[115]
LevodopaAnti Parkinson’s diseaseOralProlonged release of drug[43]
N,N Diethyl-Meta-ToluamideInsect RepellentTopicalProlong the persistence[116]
Atorvastatin CalciumAnti-hyperlipidemicOralBioavailability enhancement[117]
RosuvastatinAnti-hyperlipidemicOralBioavailability enhancement[118]
StrigolactonesAnti-cancerTargeted delivery to prostate cancer cells[66]
Salvia officinalisessential oilHypoglycemic activityOralEnhancement of stability and hypoglycemic activity[119]
RilpinavirAnti-retroviralOralIncreased in Bioavailability[74]
Norfloxacinfluoroquinolone antibioticOralEnhancement in intestinal permeation and antibacterial activity[120]
Ellagic acidAntioxidant, AnticancerOralEnhancement in oral bioavailability[121]
DoxirubicinAnti-cancerOralSite specific drug delivery[122]
Babchi oilAnti-psoriaticTopicalEnhanced photostability, solubility and anti psoriatic efficacy[123, 124]
ImiquimodAnti-cancerToipcalEnhanced skin retention and permeation[125]

Table 4.

Active molecules encapsulated in cyclodextrin based nanosponges.

5.1 Improved stability

Cyclodextrin nanosponges can prevent degradation of drug molecules which are susceptible to degradation when exposed to water, oxygen (air), heat or radiation. Such interactions are being widely studied in nanosponges. The nanosponges safeguard the drug molecules from oxidation, hydrolysis, racemization, polymerization and enzyme hydrolysis [126, 127]. A number of molecules including L-DOPA, resveratrol, camptothecin and γ-oryzanol and have been encapsulated in nanosponges are reported for stability enhancement and reported [43, 55, 58, 89]. Anandam and Selvamuthukumar found that phototability of anti-oxidant drug quercetin increased on incorporating into nanosponges. The main hindrance in its utility is its photodegradation. In addition, dissolution rate of the biomolecule was also remarkably enhanced in quercetin nanosponges.

5.2 Enhanced solubility

Poor solubility of BCS (Biopharmaceutical Classification System) class II drugs possesses a challenge in their formulation. However, these drugs can be successfully incorporated into cyclodextrin nanosponges with better efficacy. These nanocarriers improve their aqueous solubility viaformation of inclusion complexes by enhancing their wetting and solubility in water. The drug dissolution enhancement consequently enhances their bioavailability. Curcumin is a upcoming herbal active drug having potential for treatment of various fatal diseases including cancer. Though, it has higher efficacy and safety profile, its poor solubility and low bioavailability limit its therapeutic application. Darandale and Vavia fabricated cyclodextrin based nanosponges of curcumin to increase solubility and control its release. These nanosponges were obtained using dimethyl carbonate as linking agent. The prepared nanoformulation showed enhanced solubility, prolonged drug release and reduced cytotoxicity against MCF-7 cells. Besides this, other drug moieties which have been successfully encapsulated in cyclodextrin nanosponges for improved dissolution include doxorubicin [80], itraconazole [59], flurbiprofen, dexamethasone [80], telmisartan [53], tamoxifen [56], repaglinide [75] and paclitaxel [111].

5.3 Reduction in volatility of essential oil and material handling benefits

Nanosponges have been reported to protect volatile oils against lost by evaporation. These nanosponges can have resulted in long lasting effect due to slow release of chief volatile components of oils [72]. Further, volatile oil liquids (at room temperature) can be difficult to handle and hence needed to be formulate into stable solid formulations. Nanosponges may help to convert these substances into amorphous or microcrystalline powders which are convenient to handle [49].

5.4 Modulated drug release

Judicious loading of therapeutic actives into nanosponges ensures a tailored drug release. Developing controlled drug delivery systems is the topic of interest for research community while maintaining therapeutic effectiveness of drug. Employing these nanocarriers ensures optimal drug use with improved patient compliance owing to reduced frequency of administration. Nanosponges showed strong potential for providing sustained drug release in a controlled fashion. Shende et al., prepared meloxicam loaded cyclodextrin nanosponges to enhance solubility and stability and to prolong its release. In vitroand in vivoresults demonstrated controlled release of meloxicam from the nanocarrier for 24 hrs. It was discussed that slow release of drug might have been due to large degree of cross linking that permitted the entrapment of drug as inclusion complex in the nanosponges. Decrease in crystallinity and enhancement in solubility also led to improve in vitrorelease behavior [64].

5.5 Drug targeting

Besides enhancing effectiveness of drug, drug targeting also helps in reducing its adverse effects on healthy cells. By using nanosponges for drug delivery, drug is released at the specific site preventing its circulation throughout the body. A limited number of research papers were found on drug targeting using nanosponges. Harth and Diaz have widely explored nanosponges for targeted drug delivery. Polyester nanosponges were fabricated using special chemical “linkers” for delivery of anti-cancer drugs. These linkers ensure that nanosponge bound selectively to tumor cells, on injection. These nanosponges stick to the surface of tumor cells and release the drug in a controlled fashion [128].

5.6 Oral drug delivery

Oral drug delivery has been well-established route of administration having high patient compliance. However, delivery of molecules viathis route poses challenges owing to poor solubility, presystemic activation and inefficient intestinal permeability. Cyclodextrin based nanosponges have emerged as potential carriers for oral delivery without any compromise on safety issues. An excellent mini review on cyclodextrin nanosystems for oral delivery of drugs have been recently published by Adeoye and Cabral-Marques [129].

Zidan et al., have developed atorvastatin calcium for oral drug delivery by encapsulating it in β- cyclodextrin nanosponges cross linked with carbonyldiimidazole. The prepared nanosponges were found to increase bioavailability of drug up to 2.13-folds in comparison to its suspension. In addition, pharmacokinetic studies revealed remarkable decrease in total cholesterol, LDL-C (Low Density Lipoprotein Cholesterol) and triglyceride and improved level of HDL-C (High Density Lipoprotein Cholesterol) leading to improvement of liver steatosis [117].

5.7 Topical drug delivery

Nanosponges can also be incorporated in cream and gels for topical delivery of drugs. Although least explored, nanosponges may prove very promising for treatment of skin disorders viathis route. Besides drug targeting nanosponges also improved drug delivery from topical gel, if entrapped successfully. Nanosponges for topical delivery of drugs have been mentioned for resveratrol, γ-oryzanol, diclofenac sodium and babchi oil in literature [55, 89, 106, 124]. In addition, this nanoformulation also helps to alleviate local irritation problem associated with topical drugs. Conte et al., developed cyclodextrin nanosponges with pyromellitic dianhydride as cross linker and loaded them in semi-solid formulations for skin delivery. Skin permeation studies in diclofenac sodium loaded nanosponge gel and cream gels significantly retarded the drug permeation through skin while enhancing its concentration in viable epidermis and stratum corneum, confirming the localization of highly penetrating drugs in external layers of skin [11].

5.8 Pulmonary drug delivery

The pulmonary route is an alternative option to parenteral drug delivery, however, for delivery viathis route, the drug must be in the form of aerosol. The nanosponges possess the advantage of reduced interparticle attraction forces and better flow characteristics. Further, they possess low bulk density and small narrow dynamic diameter resulting in their greater deposition in lower pulmonary area. For pulmonary delivery, nanosponges of sodium cromoglicate, budesinide, bendroflumethazide using sugar excipients like trehalose and raffinose have been reported [130, 131, 132, 133].

Additionally, nanosponges have also been used for protein encapsulation, enzyme immobilization and stabilization. The enzymes like isomerase, hydrolase, oxidoreductase, ligase, and transferase has been studied. Bovine serum albumin when encapsulated as nanosponges resulted in prolonged release [13]. NS can also be employed as carrier of gases like carbondioxide and oxygen. Oxygen loaded NS can be used to supply oxygen to hypoxic tissues in different disorders [134].


6. Conclusion

Cyclodextrin nanosponges are colloidal nanoparticles made from inexpensive, biodegradable materials and can be used for internal or external administration. As such, these offer a versatile platform to address challenges like solubility, stability and toxicity for therapeutically effective drugs. Cyclodextrin nanosponges are developing rapidly in the field of nanotechnology possessing several applications in drug targeting, delivery and research, as well as in other fields. Due to their unique porous nature and size-dependent properties, they present the possibility to develop new therapeutic options. Their ability to entrap drugs and controlled release features offer a new mode in drug delivery resulting in higher levels of drug targeting. Therefore, cyclodextrin nanosponges are a great promise to achieve the goal of site specific and controlled delivery aspects and can open new perspectives in the management of complex diseases, in coming future.


The author Mr. Sunil Kumar is thankful to the Indian Council of Medical Research, New Delhi for providing Senior Research Fellowship (Letter No: 45/44/2018-Nan/BMS on dated 14/05/2018).

Conflict of interest

The authors have no conflict of interest to declare and are responsible for the content and writing of the manuscript.

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Sunil Kumar, Pooja Dalal and Rekha Rao (December 24th 2019). Cyclodextrin Nanosponges: A Promising Approach for Modulating Drug Delivery, Colloid Science in Pharmaceutical Nanotechnology, Selcan Karakuş, IntechOpen, DOI: 10.5772/intechopen.90365. Available from:

chapter statistics

374total chapter downloads

2Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Effect of Cyclodextrin Derivatization on Solubility and Efficacy of Drugs

By Syed Haroon Khalid, Mehreen Bashir, Sajid Asghar, Tauqeer Hussain Mallhi and Ikram Ullah Khan

Related Book

First chapter

Introductory Chapter: The Perspective of Emulsion Systems

By Selcan Karakuş

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us